INSULIN RECEPTOR TYROSINE KINASE SUBSTRATE

Patent №

US 6,589,935

Granted

2003-07-08

Filed 1998

Owner

INCYTE PHARMACEUTICALS, INC.

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

09046572

The invention provides a human insulin receptor tyrosine kinase substrate (IRS-p53h) and polynucleotides which identify and encode IRS-p53h. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of IRS-p53h.

PlanningC07K 14/47A61P 3/10A61P 29/00A61P 35/00A61K 38/00

AI classification

Planning0.55
Natural language0.03
Machine learning0.01
AI hardware0.00
Evolutionary computation0.00
Vision0.00
Speech0.00
Knowledge representation0.00

Ownership

INCYTE PHARMACEUTICALS, INC.

assignment · 93220780

Assignors

HILLMAN, JENNIFER L., CORLEY, NEIL C., GUEGLER, KARL J., BAUGHN, MARIAH

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC